FDA OKs Perioperative Immunotherapy for Stomach Cancer

(MedPage Today) — The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable gastric or gastroesophageal junction cancer, the agency announced on Tuesday.
Approval stipulates use of…